Navigation Links
Biomarkers in blood show potential as early detection method of pancreatic cancer
Date:1/21/2014

Researchers have identified diagnostic microRNA panels in whole blood that had the ability to distinguish, to some degree, patients with and without pancreatic cancer, according to a study in the January 22/29 issue of JAMA. The authors caution that the findings are preliminary, and that further research is necessary to understand whether these microRNAs have clinical implications as a screening test for early detection of pancreatic cancer.

MicroRNAs regulate gene expression and play important roles in the development of tumors and tumor metastasis. MicroRNA panels are a combination of several microRNAs.

Pancreatic cancer is the fourth most common cause of cancer death in the Western world and prognosis is poor, according to background information in the article. Early diagnosis of pancreatic cancer is difficult partly because it is difficult to get useful biopsies of tissue from patients suspected of having pancreatic cancer, so markers of the disease that could help with early diagnosis are needed to improve prognosis. Several specific microRNA profiles (patterns of microRNAs) have been linked to pancreatic cancer tissue. A diagnostic noninvasive blood test for pancreatic cancer would be very valuable, the authors write.

Nicolai A. Schultz, M.D., Ph.D., of Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark, and colleagues examined differences in microRNA in whole blood between patients with pancreatic cancer (n = 409) and healthy participants (n = 312) and patients with chronic pancreatitis (n = 25) to identify diagnostic panels of microRNAs for use in the diagnosis of pancreatic cancer. Serum cancer antigen 19-9 (CA19-9; an antigen that is elevated in approximately 80 percent of patients with pancreatic cancer) was also measured for comparison.

The researchers identified 2 novel panels with the potential for diagnosing pancreatic cancer.

The authors write that the test could result in referral of more individuals with symptoms to imaging. "The test could thereby diagnose more patients with pancreatic cancer, some of them at an early stage, and thus have a potential to increase the number of patients that can be operated on and possibly cured of pancreatic cancer."

They add that the harms of a high number of false-positives in screening for pancreatic cancer using an inexpensive, noninvasive blood sample from individuals with or without symptoms should be quantified in the future.

"Although we validated the panels, our findings are preliminary. Further research is necessary to understand whether these have clinical implications for early detection of pancreatic cancer and how much this information adds to serum CA19-9."

(doi:10.1001/jama.2013.284664; Available pre-embargo to the media at http://media.jamanetwork.com)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Editorial: Will Detection of MicroRNA Biomarkers in Blood Improve the Diagnosis and Survival of Patients With Pancreatic Cancer?

In an accompanying editorial, Donald J. Buchsbaum, Ph.D., of the University of Alabama, Birmingham, and Carlo M. Croce, M.D., of Ohio State University, Columbus, write that additional research is needed regarding the use of microRNAs for the early detection of pancreatic cancer.

"Even though the study was relatively large, well-conducted, and addressed the important topic of development of noninvasive methods to detect pancreatic cancer, the authors appropriately acknowledge the exploratory nature of the investigation. Given the dismal prognosis for patients with pancreatic cancer, it is important that new diagnostic approaches, such as the one used in this study, are sought. However, additional rigorous investigation will be necessary to support and extend these interesting findings."

(doi:10.1001/jama.2013.284665; Available pre-embargo to the media at http://media.jamanetwork.com)

Editor's Note: Please see the article for additional information, including financial disclosures, funding and support, etc.


'/>"/>

Contact: Julia S. Johansen
julia.johansen@post3.tele.dk
The JAMA Network Journals
Source:Eurekalert

Related medicine news :

1. Molecular Biomarkers for Cancer Detection and Management
2. MUHC researchers identify biomarkers that could leadto early diagnosis of colorectal cancer
3. Mount Sinai Researchers Identify Mechanisms and Potential Biomarkers of Tumor Cell Dormancy
4. Global Biomarkers Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
5. Macrophage-derived mediators may have potential as biomarkers for urinary stone risk
6. Biomarkers Market Worth $25.79 Billion by 2016 – New Report by MarketsandMarkets
7. Researchers to identify genetic biomarkers for aggressive breast cancer
8. Researchers develop specific tests to identify cancer biomarkers in dermatomyositis
9. Global Oncology Biomarkers Market to Reach US $9.5 Billion by 2014 at a CAGR of 18.1% - New Report by MarketsandMarkets
10. New concussion data: 2 biomarkers better than 1
11. Researchers narrow the search for biomarkers of drug resistance in head and neck cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... MN (PRWEB) , ... September 22, 2017 , ... MEDIA ... at its rally to interview citizens on why they are rallying against Mayo Clinic. ... commitment to this effort against Dr. Noseworthy’s (CEO) decision to close the Albert Lea ...
(Date:9/22/2017)... ... September 22, 2017 , ... On Sunday, September 24, hundreds will gather at ... Joyner, still considered the fastest woman of all time. Flo Jo passed away ... will sing the National Anthem. Mary was a contestant on the 2012 season ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... they often saves lives. However, if one isn’t accessible in certain locations, the ... of defibrillation, I came up with this idea," said an inventor from Ridgecrest, ...
(Date:9/22/2017)... ... 22, 2017 , ... Fenwick Agency of Plano, TX has announced the commencement ... of the nationally recognized ‘Agents of Change’ movement. The agency pledges to select a ... to seek out those who most need help. Their hope is to bring awareness ...
(Date:9/22/2017)... New York (PRWEB) , ... September 22, 2017 ... ... delivers and assembles Passive House buildings, and Richard Pedranti Architect (RPA), ... Passive House from the strategic partner’s Solsken Line of Model Homes . ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... 22, 2017 AVACEN Medical (AVACEN) announced that ... successfully helping those with the widespread pain associated with ... Amanda in Essex, England commented, ... hair, experiencing no sleep at all, tremendous pain, with ... cannot recommend [the AVACEN 100] enough, how this has ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform ... leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led ...
(Date:9/19/2017)... , Sept. 19, 2017   ZirMed Inc ., a ... today announced that it has been ranked #1 by its ... Book™ Rankings 2017 User Survey. ZirMed was recognized as ... large hospitals and medical centers over 200 beds and holds ... healthcare technology user survey history. ...
Breaking Medicine Technology: